MA39260A1 - (2-aza-bicyclo [2.2.1] heptane-3-carboxylic acid (substituted benzyl-cyano-methyl) -amides used as inhibitors of - Google Patents

(2-aza-bicyclo [2.2.1] heptane-3-carboxylic acid (substituted benzyl-cyano-methyl) -amides used as inhibitors of

Info

Publication number
MA39260A1
MA39260A1 MA39260A MA39260A MA39260A1 MA 39260 A1 MA39260 A1 MA 39260A1 MA 39260 A MA39260 A MA 39260A MA 39260 A MA39260 A MA 39260A MA 39260 A1 MA39260 A1 MA 39260A1
Authority
MA
Morocco
Prior art keywords
aza
bicyclo
heptane
cyano
inhibitors
Prior art date
Application number
MA39260A
Other languages
French (fr)
Original Assignee
Boehringer Ingelheim Int
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim Int filed Critical Boehringer Ingelheim Int
Priority to MA39260A priority Critical patent/MA39260A1/en
Publication of MA39260A1 publication Critical patent/MA39260A1/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

La présente invention concerne des (benzyl-cyano-méthyl)-amides de l'acide 2-aza-bicyclo[2.2.1]heptane-3-carboxylique de formule (1) et leur utilisation comme inhibiteurs de la cathépsine c, des compositions pharmaceutiques contenant ceux-ci, et des méthodes d'utilisation de ceux-ci comme agents pour le traitement et/ou la prévention de maladies associées à l'activité de la dipeptidyl peptidase i, par exemple des maladies respiratoires.The present invention relates to (benzyl-cyano-methyl) -amides of 2-aza-bicyclo [2.2.1] heptane-3-carboxylic acid of formula (1) and their use as cathepsin-c inhibitors, compositions pharmaceutical compositions containing these, and methods of use thereof as agents for the treatment and / or prevention of diseases associated with the activity of dipeptidyl peptidase i, for example respiratory diseases.

MA39260A 2014-03-12 2014-03-12 (2-aza-bicyclo [2.2.1] heptane-3-carboxylic acid (substituted benzyl-cyano-methyl) -amides used as inhibitors of MA39260A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
MA39260A MA39260A1 (en) 2014-03-12 2014-03-12 (2-aza-bicyclo [2.2.1] heptane-3-carboxylic acid (substituted benzyl-cyano-methyl) -amides used as inhibitors of

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
MA39260A MA39260A1 (en) 2014-03-12 2014-03-12 (2-aza-bicyclo [2.2.1] heptane-3-carboxylic acid (substituted benzyl-cyano-methyl) -amides used as inhibitors of

Publications (1)

Publication Number Publication Date
MA39260A1 true MA39260A1 (en) 2018-04-30

Family

ID=62217528

Family Applications (1)

Application Number Title Priority Date Filing Date
MA39260A MA39260A1 (en) 2014-03-12 2014-03-12 (2-aza-bicyclo [2.2.1] heptane-3-carboxylic acid (substituted benzyl-cyano-methyl) -amides used as inhibitors of

Country Status (1)

Country Link
MA (1) MA39260A1 (en)

Similar Documents

Publication Publication Date Title
PH12015501964A1 (en) Substituted 2-aza-bicyclo[2.2.1]heptane-3-carboxylic acid (benzyl-cyano-methyl)-amides inhibitors of cathepsin c
MA38483A1 (en) Inhibitors of ido
EA201990019A1 (en) COMPOUNDS AND COMPOSITIONS FOR SUSPENSION OF SHP2 ACTIVITY
MA38380A1 (en) Quinazoline inhibitors of activation of mutant forms of epidermal growth receptor (EGFR)
MA39219A1 (en) New lrrk2 Kinase Inhibitor Compounds Used to Treat Parkinson's, Alzheimer's and Amyotrophic Lateral Sclerosis
MA41179A (en) PARG INHIBITOR COMPOUNDS
MA44948A1 (en) Bace 1 inhibitors
PH12017500841A1 (en) 2-amino-6-(difluoromethyl)- 5,5-difluoro-6-phenyl-3,4,5,6-tetrahydropyridines as bace1 inhibitors
EA201790576A1 (en) Spirocyclic inhibitors of katepsin C
MA38810B1 (en) Inhibitors of rorc2 related methods of use
EA201590066A1 (en) DIFTORGEXAHYDROCYCLOPENTAXOXASYNYLES AND DIFTORGEXAHYDROBENZOXASYNYLES AS BETA SECRETASE INHIBITORS
MA37691B1 (en) 5-amino [1,4] thiazines as bace1 inhibitors
MA43052B1 (en) Human Plasma Kallikrein Inhibitors
EA202092326A1 (en) BUMETHANIDE DERIVATIVES FOR THE TREATMENT OF HYPERHYDROSIS
MA39533B1 (en) Compounds, pharmaceutical composition and their use in the treatment of neurodegenerative diseases
MA38473B1 (en) (2-aza-bicyclo [2.2.1] heptane-3-carboxylic acid (substituted benzyl-cyano-methyl) -amides used as inhibitors of
MA39260A1 (en) (2-aza-bicyclo [2.2.1] heptane-3-carboxylic acid (substituted benzyl-cyano-methyl) -amides used as inhibitors of
MA43263B1 (en) Heterocyclic compounds used as immunomodulators
MA56098B1 (en) HETEROCYCLIC IMMUNOMODULATORS AS WELL AS PDL1 INHIBITORS
MA44144A (en) HETEROCYCLIC COMPOUNDS USED AS IMMUNOMODULATORS
MA45392B1 (en) Heterocyclic compounds used as immunomodulators
EA201890514A1 (en) CONNECTION TETRAGIDROOXEPIPINOPYRIDINE
FR3042191B1 (en) 1,4,8-TRIAZAPHENANTHRENE DERIVATIVES FOR THE TREATMENT OF NEURODEGENERATIVE DISEASES
MA39719B1 (en) Pyrazoles substituted with trifluoromethyl as inhibitors of human plasma kallikrein
MA37957A1 (en) Methods of treating alzheimer's disease and associated pharmaceutical compositions